Analysts Set Expectations for BCRX Q1 Earnings
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Investment analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of BioCryst Pharmaceuticals in a research note issued to investors on Tuesday, February 25th. Wedbush analyst L. Chico forecasts that the biotechnology company will post earnings of ($0.06) per share for the quarter. […]
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) – Investment analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of BioCryst Pharmaceuticals in a research note issued to investors on Tuesday, February 25th. Wedbush analyst L. Chico forecasts that the biotechnology company will post earnings of ($0.06) per share for the quarter. […]
